NewsOK Local Stocks
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Vertex Pharmaceuticals (NQ: VRTX)
209.80 USD  +4.80 (+2.34%)
Official Closing Price  /  Updated: 7:12 PM EST, Nov 15, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,581,400
Open 205.95
Bid (Size) 208.00 (2)
Ask (Size) 213.50 (1)
Prev. Close 205.00
Today's Range 205.01 - 210.05
52wk Range 151.80 - 210.05
Shares Outstanding 254,830,232
Dividend Yield N/A
Performance
YTD
+27.86%
+27.86%
1 Month
+18.05%
+18.05%
3 Month
+12.14%
+12.14%
6 Month
+26.59%
+26.59%
1 Year
+27.07%
+27.07%
Top News
More News
Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that NHS Wales has accepted an offer for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of... Read More
from Business Wire News Releases
Vertex Confirms Northern Ireland Offer Accepted for Cystic Fibrosis Medicines
Vertex confirms Northern Ireland offer accepted for cystic fibrosis medicines. Read More
from Business Wire News Releases
More News
Read More
Vertex Pharm Has Returned 15.3% Since SmarTrend Recommendation (VRTX)
from Comtex SmarTrend® News Briefs
Vertex Pharmaceuticals Takes Over #116 Spot From DuPont
category Stocks
from Market News Video
UPDATE 1-Vertex deal with Wales expands cystic fibrosis treatment coverage to all of UK
category companyNews
from Reuters: Company News
Vertex reaches deal with Wales for cystic fibrosis treatment
category companyNews
from Reuters: Company News
Vertex to Present at the Credit Suisse Healthcare Conference on November 12
from Business Wire News Releases
CORRECTED-INSIGHT-US company directors compensated more than ever, but now risk backlash
category companyNews
from Reuters: Company News
Here's Why Solid Biosciences Collapsed Today
category SRPT , PFE , Market News , and 3 more.
from Motley Fool
2 Beaten-Down Biotech Stocks That Could Make You Rich
category BMRN , VRTX , SRPT , and 1 more.
from Motley Fool
INSIGHT-US company directors compensated more than ever, but now risk backlash
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.